Eupraxia Pharmaceuticals Inc. EPS (Diluted) for the year ending December 31, 2024: USD -0.72

Eupraxia Pharmaceuticals Inc. EPS (Diluted) is USD -0.72 for the year ending December 31, 2024, a -39.96% change year over year. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.
  • Eupraxia Pharmaceuticals Inc. EPS (Diluted) for the year ending December 31, 2023 was USD -1.19, a 33.55% change year over year.
  • Eupraxia Pharmaceuticals Inc. EPS (Diluted) for the year ending December 31, 2022 was USD -0.89, a -29.87% change year over year.
  • Eupraxia Pharmaceuticals Inc. EPS (Diluted) for the year ending December 31, 2021 was USD -1.27, a 423.19% change year over year.
  • Eupraxia Pharmaceuticals Inc. EPS (Diluted) for the year ending December 31, 2020 was USD -0.24, a -43.53% change year over year.
Key Data
Date EPS (Diluted) Shares (Diluted, Weighted) Selling, General, and Administrative Expenses (SG&A) Research and Development (R&D) Expenses